background
role
virus
children
respiratori
tract
infect
humor
immunodefici
hardli
studi
evalu
infect
children
humor
immunodefici
requir
immunoglobulin
replac
therapi
consid
relationship
symptom
lung
function
bacteri
coinfect
outcom
conduct
prospect
casecontrol
studi
period
includ
children
humor
immunodefici
receiv
immunoglobulin
replac
therapi
patient
least
one
healthi
famili
member
includ
respiratori
sampl
viral
detect
taken
everi
month
case
respiratori
tract
infect
symptom
questionnair
fill
biweekli
spirometri
sputum
cultur
perform
everi
episod
result
sixtysix
episod
analyz
patient
median
age
year
iqr
identifi
respiratori
virus
rhinoviru
frequent
isol
one
posit
viral
episod
associ
clinic
symptom
vs
frequent
antibiot
treatment
vs
hospit
admiss
vs
neg
one
patient
posit
viral
detect
show
impair
lung
function
lower
fvc
valu
conclus
experi
viral
respiratori
tract
infect
caus
signific
respiratori
symptom
impair
lung
function
children
hid
despit
immunoglobulin
replac
therapi
patient
could
benefit
monitor
viral
infect
may
gateway
ongo
lung
damag
k
e
w
r
humor
immunodefici
immunoglobulin
replac
therapi
lung
function
respiratori
tract
infect
viru
marta
benavidesnieto
ana
share
first
authorship
children
sever
tcell
immunodefici
present
impair
clearanc
respiratori
virus
pulmonari
complic
viral
infect
lead
caus
morbid
mortal
group
patient
howev
role
respiratori
virus
children
type
primari
immunodefici
pid
mainli
humor
immunodefici
hid
diseas
immun
dysregul
hardli
studi
children
hid
usual
suffer
recurr
bacteri
respiratori
infect
result
progress
bronchiectasi
chronic
lung
diseas
immunoglobulin
replac
therapi
irt
reduc
frequenc
infect
howev
despit
adequ
irt
recurr
respiratori
infect
still
one
lead
caus
morbid
mortal
patient
littl
data
current
avail
regard
suscept
respiratori
virus
hypogammaglobulinem
patient
receiv
irt
howev
virus
describ
play
signific
role
patient
human
herpesviru
associ
granulomatouslymphocyt
interstiti
lung
diseas
glild
patient
common
variabl
immunodefici
cvid
enteroviru
known
caus
fatal
meningoenceph
patient
xlink
agammaglobulinemia
xla
addit
sever
recent
report
show
increas
suscept
viral
respiratori
infect
adult
cvid
receiv
irt
contribut
chronic
persist
pulmonari
inflamm
report
best
knowledg
first
studi
analys
respiratori
virus
pediatr
patient
predominantli
antibodi
defici
requir
irt
consid
relationship
clinic
symptom
pulmonari
function
bacteri
coinfect
treatment
outcom
conduct
prospect
casecontrol
singlecent
studi
year
novemb
octob
nation
refer
unit
pid
madrid
spain
includ
patient
less
year
age
diagnos
hid
requir
irt
patient
combin
immunodefici
andor
reduc
prolif
respons
mitogen
pha
pwm
cona
exclud
patient
hid
requir
irt
andor
patient
receiv
immunosuppress
treatment
rituximab
exclud
committe
inform
consent
obtain
patient
parent
patient
healthi
control
includ
usual
one
parent
respiratori
sampl
nasopharyng
aspir
npa
patient
nasopharyng
swab
control
obtain
everi
one
three
month
coincid
intraven
immunoglobulin
administr
outpati
clinic
evalu
patient
control
group
investig
perform
visit
patient
group
includ
spirometri
patient
older
year
spontan
sputum
cultur
patient
older
year
igg
level
full
blood
count
fbc
creactiv
protein
erythrocyt
sediment
rate
esr
patient
develop
respiratori
symptom
visit
addit
sputum
cultur
nasopharyng
aspir
perform
first
day
symptom
onset
well
addit
spirometri
children
older
year
age
need
antibiot
treat
respiratori
infect
sputum
sampl
obtain
start
therapi
everi
moment
respiratori
sampl
obtain
patient
defin
episod
symptom
questionnair
elabor
ad
hoc
fill
systemat
biweekli
patient
control
record
fever
increas
respiratori
secret
cough
respiratori
distress
sputum
three
independ
rtpcr
assay
perform
detect
sixteen
respiratori
virus
previous
publish
group
influenza
b
c
virus
detect
use
previous
describ
primer
set
amplifi
influenza
virus
multiplex
pcr
assay
second
multiplex
pcr
use
detect
parainfluenza
virus
human
coronavirus
enterovirus
rhinovirus
rv
presenc
respiratori
syncity
viru
rsv
b
type
human
metapneumoviru
human
bocaviru
adenovirus
investig
third
multiplex
rtnest
pcrbrq
method
spontan
sputum
sampl
collect
use
steril
specimen
contain
immedi
process
store
benavidesnieto
et
al
process
feasibl
sampl
cultur
standard
media
potenti
respiratori
tract
pathogen
identifi
test
antimicrobi
suscept
pulmonari
function
test
perform
patient
studi
entri
repeat
everi
sampl
collect
spirometri
perform
accord
establish
guidelin
studi
period
patient
predominantli
antibodi
defici
includ
girl
boy
main
immunolog
diagnos
report
tabl
median
age
patient
year
iqr
two
younger
year
eleven
patient
receiv
intraven
irt
three
patient
subcutan
irt
immunolog
statu
inclus
describ
tabl
eighteen
healthi
adult
famili
member
mother
andor
father
patient
includ
healthi
control
subject
least
one
control
per
case
includ
hand
author
hypothes
persist
recurr
viral
respiratori
infect
could
advers
affect
microbiom
lead
increas
bacteri
densiti
children
nasopharyng
tract
predispos
sinopulmonari
bacteri
infect
author
recommend
screen
viral
infect
children
hid
acut
respiratori
symptom
avoid
unnecessari
antibiot
treatment
howev
viral
test
routin
perform
children
sever
combin
immunodefici
scid
regard
hid
protocol
present
great
deal
variat
across
europ
manag
lung
complic
urgent
need
consensu
guidelin
monitor
lung
complic
treat
respiratori
infect
hid
patient
patient
typic
hid
xla
cvid
three
case
scid
patient
receiv
hematopoiet
cell
transplant
present
persist
bcell
lymphopenia
hypogammaglobulinemia
although
children
scid
recov
cellular
immun
year
transplant
mani
patient
like
irt
consider
period
full
reconstitut
bcell
immun
achiev
bcell
immun
reconstitut
consequ
regard
viral
respiratori
infect
deepli
investig
patient
data
support
patient
also
prone
viral
respiratori
infect
impact
lung
function
lead
antibiot
consumpt
anoth
patient
adhi
regard
humor
immun
mani
patient
adhi
requir
immunoglobulin
infus
due
memori
bcell
lymphopenia
declin
specif
antibodi
titer
recurr
respiratori
tract
infect
describ
children
develop
pneumonia
although
bacteria
detect
respiratori
exacerb
viral
pneumonia
also
report
lung
sequela
patient
frequent
mainli
bronchiectasi
thu
monitor
viral
infect
children
may
import
one
patient
seri
suffer
diseas
heterogen
respiratori
infect
complic
frequent
often
sever
spectrum
pathogen
highli
reminisc
primari
antibodi
defici
syndrom
cvid
coulter
et
al
seem
play
role
children
hid
also
describ
adult
studi
need
improv
knowledg
impact
respiratori
viral
infect
prevent
manag
children
irt
aim
avoid
shortand
longterm
consequ
